Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinson’s Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinson’s disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Avastin Health Risks Lead To Removal of Breast Cancer Approval December 17, 2010 Staff Writers Add Your CommentsFederal regulators have announced that the cancer drug Avastin will soon lose its approval for the treatment of breast cancer in the United States. The decision to revoke Avastin’s indication for breast cancer treatment was announced by the FDA on Thursday and comes after a review that shows that the drug does little to help breast cancer patients.There are a number of potential Avastin side effects, which the FDA has decided outweigh the drug’s limited health benefits. The potential health risks of Avastin may include severe high blood pressure, heart attacks, heart failure, bleeding and hemorrhaging, and the development of perforations in the nose, stomach and intestines.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know About…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe revocation will not happen immediately. Genentech will have 15 days to request a hearing in writing challenging the decision. If the company chooses to do so, there will be a hearing open to the public where the company can present evidence to the FDA to attempt to sway the agency from removing Avastin breast cancer approval.Doctors will still be able to prescribe Avastin for breast cancer treatment, however it is unlikely that most insurance companies would cover the drug’s use, driving the cost out of reach for most patients.Some women have said that Avastin has worked well on their breast cancer, but the FDA said that it must rely on the clinical trials and not anecdotal evidence. FDA officials said that there could be any number of reasons some women have seen significant cancer benefits while on Avastin that are not linked to the drug’s effectiveness.Avastin (bevacizumab) was approved by the FDA in 2004 for treatment of non-small cell lung cancer and colorectal cancer when combined with chemotherapy. It was then was granted accelerated approval for use with paclitaxel to treat breast cancer patients by FDA in February 2008. The drug prevents the formation of new blood vessels in tumors, starving them and inhibiting their growth.The approval of Avastin for breast cancer treatment was based on a clinical trial finding that it slowed the growth of breast cancer tumors, at odds with the usual requirement that breast cancer treatment drugs show that they actually extend the lives of patients. As part of the accelerated approval process, Genentech, a subsidiary of Roche, had to continue two more drug trials and then submit their findings to FDA.In July, an FDA advisory committee voted 12-1 to remove the breast cancer indication. However the advisory committee’s vote is non-binding and the FDA had to come to its own conclusion. Drug reviewers looked at clinical data from four independent studies, and found that the use of Avastin did not significantly extend the lives of breast cancer patients, and had little effect on tumors.“None of the studies demonstrated that patients receiving Avastin lived longer and patients receiving Avastin experienced a significant increase in serious side effects,” said Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research. “The limited effects of Avastin combined with the significant risks led us to this difficult decision. The results of these studies are disappointing.”Woodcock said that the FDA encouraged Genentech to conduct additional research to identify any specific groups of patients that might derive a benefit from using Avastin to treat breast cancer.The FDA’s decision will not result in an Avastin recall, as the medication remains approved for other uses. Tags: Avastin, Breast Cancer, Chemotherapy, Genentech, Heart Attack, Heart Failure, Roche Image Credit: |More Lawsuit Stories Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss November 18, 2026 IVC Filter Lawsuit Claims Broken Cook Celect Device Left Metal Embedded in Man’s Spine November 18, 2026 Lawsuit Claims Hidden AirTags Used to Stalk and Abuse Mother of Four for Years November 18, 2026 1 Comments KJ December 26, 2010 ‘- – fortunately, I stopped on the Avastin trial after two treatments — as a supplement to all the conventional breast cancer treatments. That was almost 4 years ago; the side effects linger. FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: today)A Washington woman’s lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026) DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: yesterday)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026) Nitrous Oxide Injury Lawsuit Targets Amazon, Online Retailers for Illegal Drug Sales (Posted: 2 days ago)About 100 different plaintiffs have filed a lawsuit alleging Amazon served as the storefront for multiple illicit nitrous oxide dealers, leading to severe injuries and addiction.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Paralysis Lawsuit Filed Against Galaxy Gas (11/04/2026)Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (10/15/2026)Nitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026)
IVC Filter Lawsuit Claims Broken Cook Celect Device Left Metal Embedded in Man’s Spine November 18, 2026
Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: today)A Washington woman’s lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: yesterday)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026)
Nitrous Oxide Injury Lawsuit Targets Amazon, Online Retailers for Illegal Drug Sales (Posted: 2 days ago)About 100 different plaintiffs have filed a lawsuit alleging Amazon served as the storefront for multiple illicit nitrous oxide dealers, leading to severe injuries and addiction.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Paralysis Lawsuit Filed Against Galaxy Gas (11/04/2026)Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (10/15/2026)Nitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026)